|
5 Companies |
|
4 Products |
|
4 Products |
|
9 Mechanisms of Action |
|
0 Trials |
|
28 News |
|
- | Trial completion, Trial completion date, Trial primary completion date: Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (clinicaltrials.gov) - Jul 6, 2018
P=N/A, N=74, Completed, Sponsor: Prof. Arie Levine
Recruiting --> Completed | Trial completion date: Apr 2018 --> Jul 2018 | Trial primary completion date: Apr 2018 --> Jul 2018
- | Trial primary completion date: Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=72, Recruiting, Sponsor: Prof. Arie Levine
Recruiting --> Completed | Trial completion date: Apr 2018 --> Jul 2018 | Trial primary completion date: Apr 2018 --> Jul 2018 Trial primary completion date: Jul 2017 --> Apr 2018
- | Trial completion: The ImageKids Study: Developing the pMEDIC and the PICMI (clinicaltrials.gov) - May 1, 2017
P=N/A, N=240, Completed, Sponsor: Shaare Zedek Medical Center
Trial primary completion date: Jul 2017 --> Apr 2018 Recruiting --> Completed
- Remicade (infliximab) / J&J
Phase classification: Protein and Energy Metabolism in Pediatric Crohn's Disease (clinicaltrials.gov) - Mar 15, 2017
P1, N=15, Completed, Sponsor: Indiana University
Recruiting --> Completed Phase classification: P=N/A --> P1
- Phase classification, Trial primary completion date: Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (clinicaltrials.gov) - Jan 23, 2017
P=N/A, N=72, Recruiting, Sponsor: Prof. Arie Levine
Phase classification: P=N/A --> P1 Phase classification: P4 --> P=N/A | Trial primary completion date: Jul 2016 --> Jul 2017
- | Remicade (infliximab) / J&J
Trial completion, Enrollment change, Trial primary completion date: Protein and Energy Metabolism in Pediatric Crohn's Disease (clinicaltrials.gov) - Aug 3, 2016
P=N/A, N=15, Completed, Sponsor: Indiana University
Phase classification: P4 --> P=N/A | Trial primary completion date: Jul 2016 --> Jul 2017 Active, not recruiting --> Completed | N=34 --> 15 | Trial primary completion date: Jan 2012 --> Dec 2008
- Trial primary completion date: The ImageKids Study: Developing the pMEDIC and the PICMI (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=240, Recruiting, Sponsor: Shaare Zedek Medical Center
Active, not recruiting --> Completed | N=34 --> 15 | Trial primary completion date: Jan 2012 --> Dec 2008 Trial primary completion date: Jun 2016 --> Jan 2017
- Trial completion: Belcro: Registry of Pediatric Patients Diagnosed With Crohn's Disease in Belgium (clinicaltrials.gov) - Jan 20, 2016
P=N/A, N=257, Completed, Sponsor: Gigi Veereman
Trial primary completion date: Jun 2016 --> Jan 2017 Active, not recruiting --> Completed
- Remicade (infliximab) / J&J
Enrollment change, Trial termination, Trial primary completion date, Monotherapy, Immunomodulating: Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure (clinicaltrials.gov) - Dec 23, 2015
P4, N=20, Terminated, Sponsor: Prof. Arie Levine
Active, not recruiting --> Completed N=90 --> 20 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Dec 2015; lack of budget and failure to reach milestones
- Trial primary completion date: Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (clinicaltrials.gov) - Dec 9, 2015
P4, N=72, Recruiting, Sponsor: Prof. Arie Levine
N=90 --> 20 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Dec 2015; lack of budget and failure to reach milestones Trial primary completion date: Jul 2015 --> Jul 2016
- Trial completion, Trial primary completion date: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease (clinicaltrials.gov) - Dec 9, 2015
P4, N=73, Completed, Sponsor: Prof. Arie Levine
Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Dec 2015
- Enrollment change, Trial withdrawal: Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease (clinicaltrials.gov) - Aug 24, 2015
P=N/A, N=0, Withdrawn, Sponsor: Medical College of Wisconsin
Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Dec 2015 N=1500 --> 0 | Recruiting --> Withdrawn
- Trial primary completion date: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease (clinicaltrials.gov) - Jun 11, 2015
P4, N=70, Recruiting, Sponsor: Prof. Arie Levine
N=1500 --> 0 | Recruiting --> Withdrawn Trial primary completion date: Apr 2015 --> Aug 2015
- Remicade (infliximab) / J&J
Enrollment open, Monotherapy, Immunomodulating: Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure (clinicaltrials.gov) - Apr 7, 2014
P4, N=90, Recruiting, Sponsor: Prof. Arie Levine
Trial primary completion date: Apr 2015 --> Aug 2015 Not yet recruiting --> Recruiting
- Enrollment open: Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (clinicaltrials.gov) - Apr 5, 2014
P4, N=72, Recruiting, Sponsor: Prof. Arie Levine
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Enrollment change: Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease (clinicaltrials.gov) - Mar 5, 2014
P3, N=12, Completed, Sponsor: Children's Mercy Hospital Kansas City
Not yet recruiting --> Recruiting N=30 --> 12
- || Trial completion: Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease (clinicaltrials.gov) - Mar 5, 2014
P3, N=12, Completed, Sponsor: Children's Mercy Hospital Kansas City
N=30 --> 12 Recruiting --> Completed
- Trial completion: Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial (clinicaltrials.gov) - Aug 1, 2013
P=N/A, N=138, Completed, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Completed Active, not recruiting --> Completed
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Clinical: Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease (clinicaltrials.gov) - Mar 4, 2013
P4, N=0, Withdrawn, Sponsor: University of Roma La Sapienza
Active, not recruiting --> Completed Active, not recruiting --> Withdrawn
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Clinical: Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease (clinicaltrials.gov) - Mar 4, 2013
P4, N=0, Withdrawn, Sponsor: University of Roma La Sapienza
Active, not recruiting --> Withdrawn N=50 --> 0
- | Remicade (infliximab) / J&J
New P4 trial, Monotherapy, Immunomodulating: Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure (clinicaltrials.gov) - Feb 27, 2013
P4, N=90, Recruiting, Sponsor: Prof. Arie Levine
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Clinical: Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease (clinicaltrials.gov) - Dec 17, 2012
P4, N=0, Withdrawn, Sponsor: University of Roma La Sapienza
- | New P4 trial: Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (clinicaltrials.gov) - Nov 18, 2012
P4, N=72, Recruiting, Sponsor: Prof. Arie Levine
- Enrollment open: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease (clinicaltrials.gov) - Oct 14, 2012
P4, N=70, Recruiting, Sponsor: Prof. Arie Levine
N=50 --> 0 Not yet recruiting --> Recruiting
- Remicade (infliximab) / J&J
New P3 trial, IO biomarker: Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-? Therapy (clinicaltrials.gov) - Aug 7, 2012
P3, N=20, Completed, Sponsor: Samsung Medical Center
- | New P4 trial: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease (clinicaltrials.gov) - May 9, 2012
P4, N=70, Recruiting, Sponsor: Prof. Arie Levine
- Trial completion: Vitamin D in Pediatric Crohn's Disease (clinicaltrials.gov) - Feb 9, 2012
P4, N=87, Completed, Sponsor: University of British Columbia
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment change: High Dose Oral 4-Aminosalicylic Acid (PASER (clinicaltrials.gov) - Oct 19, 2011
P2, N=2, Terminated, Sponsor: Jacobus Pharmaceutical
Recruiting --> Completed N=54 --> 2